How Exercise May Help Calm the Immune System in Type 1 Diabetes

Type 1 diabetes develops when the immune system mistakenly attacks the beta cells in the pancreas that produce insulin. Unlike advances in insulin pumps and glucose monitors—which help manage blood sugar—these tools don't address the underlying autoimmune process. Researchers are searching for safe, low-risk strategies that could help calm this immune attack.

Exercise triggers changes throughout the immune system. Physical activity affects both innate immunity (the immune system's rapid first response) and adaptive immunity (the more targeted, long-term response). Exercise alters immune cell types, shifts the balance of signaling molecules called cytokines and chemokines, and activates special molecules produced by muscle during physical activity known as exerkines.

Some of these exerkines, including meteorin-like protein and irisin, appear to have anti-inflammatory properties—meaning they help reduce harmful immune inflammation.

In preclinical research using lab models and rodent studies, exercise demonstrated several protective effects. Physical activity reduced inflammation within the islets of Langerhans (the clusters of cells containing beta cells), limited the number of immune cells infiltrating these tissues, and protected beta cells from damage caused by inflammatory cytokines. These findings suggest a biological mechanism by which exercise could slow the autoimmune process.

Clinical studies examining people with Type 1 diabetes have found links between higher physical activity levels and delayed disease progression. Some individuals who exercise more show slower advancement of islet autoimmunity—the process of immune cells attacking the insulin-producing tissue. Others demonstrate longer periods of partial remission, when beta cell function persists. Additionally, people with Type 1 diabetes who maintain active lifestyles show immune signatures consistent with lower inflammation.

However, the number of human studies remains small, and researchers emphasize that direct clinical evidence is still limited.

The convergence of laboratory findings, animal studies, and early human data suggests exercise may play a role in modulating the immune dysfunction that drives Type 1 diabetes. Physical activity remains a cornerstone of diabetes management for its well-established metabolic benefits. The emerging research hints that immune modulation could be an additional benefit worth exploring further.

Much work remains to fully understand how exercise influences Type 1 diabetes immunity and to determine which types, intensities, and durations of activity may be most beneficial. Current evidence does not position exercise as a replacement for insulin therapy or standard medical care, but rather as a potentially valuable complement to comprehensive diabetes management.

Source: Diabetes care. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.